share_log

Morgan Stanley Maintains Equal-Weight on Graphite Bio, Lowers Price Target to $3

Benzinga Real-time News ·  Feb 3, 2023 08:24

Morgan Stanley analyst Jeffrey Hung maintains Graphite Bio (NASDAQ:GRPH) with a Equal-Weight and lowers the price target from $6 to $3.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment